Skip to main content
. Author manuscript; available in PMC: 2021 Oct 1.
Published in final edited form as: Gynecol Oncol. 2020 Jul 21;159(1):17–22. doi: 10.1016/j.ygyno.2020.07.016

Figure 1:

Figure 1:

Uterine serous carcinoma. a. papillary growth pattern b. malignant cells with prominent nucleoli and brisk mitotic activity c. HER2 immunohistochemical staining with 3+ staining pattern.